| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 06/23/2004 | CN1154745C Method of utilizing antisense gene in controlling protein and oil content of seed |
| 06/23/2004 | CN1154742C Recombinant MVA virus, and the use thereof |
| 06/23/2004 | CN1154741C Chimera gene with serveral herbicide resistant genes, plant cell and plant resistant to serveral herbicides |
| 06/23/2004 | CN1154739C System for mass production of proteins or prptides by microorganisms of genus humicola |
| 06/23/2004 | CN1154737C Transgenic plants with altered senescence characteristics |
| 06/23/2004 | CN1154734C Mutated 5-enol pyruvylshikimate-3-phosphate sythase, gene coding for said protein and transformed plants containing said gene |
| 06/23/2004 | CN1154733C Improved heat-stable DNA polymerase |
| 06/23/2004 | CN1154729C Staphylokinase derivs |
| 06/23/2004 | CN1154723C Floral organ-specific genes and promoter sequences thereof |
| 06/23/2004 | CN1154721C Enzyme endoglucanase and cellulase preparations containing the same |
| 06/23/2004 | CN1154720C Beta-fructofuranosidase and gene thereof |
| 06/23/2004 | CN1154719C Aldehyde dehydrogenase |
| 06/23/2004 | CN1154718C Method of screening oxynitrilase microbe |
| 06/23/2004 | CN1154414C Virus-resistant plant cells and process for constructing same |
| 06/23/2004 | CA2415062A1 Methods and genetic sequences for modulating tuber formation in tuber-producing plants, and plants genetically modified to alter tuber size and number |
| 06/22/2004 | US6753461 Method for increasing stress-resistance to a plant |
| 06/22/2004 | US6753423 For preferentially modulated gene expression in liver and associated tissues |
| 06/22/2004 | US6753416 Modifications of the VEGF receptor-2 protein and methods of use |
| 06/22/2004 | US6753411 Genetic engineering; insertion vector into polypeptides |
| 06/22/2004 | US6753176 Genetic engineering; antiarthritic agents |
| 06/22/2004 | US6753175 Antiinflammatory agents; anticancer agents; cardiovascular disorders; genetic engineering; transgenic animals |
| 06/22/2004 | US6753173 Methods to mediate polyketide synthase module effectiveness |
| 06/22/2004 | US6753172 For the treatment of bacterial infection, detecting diseases related to the presence of fabi nucleic acid sequences |
| 06/22/2004 | US6753167 Preparation of heterologous proteins on oil bodies |
| 06/22/2004 | US6753163 Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
| 06/22/2004 | US6753162 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
| 06/22/2004 | US6752987 Adenovirus encoding human adenylylcyclase (AC) VI |
| 06/20/2004 | CA2453872A1 Heat-labile desoxyribonuclease i variants |
| 06/17/2004 | WO2004050907A2 Method for determing predisposition to manifestation of immune system related diseases |
| 06/17/2004 | WO2004050904A1 Prothrombin purification |
| 06/17/2004 | WO2004050899A2 Method for in vitro selection of 2’-substituted nucleic acids |
| 06/17/2004 | WO2004050884A2 Novel neomycin phosphotransferase genes and method for the selection of high-producing recombinant cells |
| 06/17/2004 | WO2004050883A2 Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis b core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine |
| 06/17/2004 | WO2004050882A1 Bioremediation with transgenic plants |
| 06/17/2004 | WO2004050875A1 Novel aromatic ring dioxygenase genes and use thereof |
| 06/17/2004 | WO2004050872A1 Modified lacz gene |
| 06/17/2004 | WO2004050867A1 MODIFIED L49-sFv EXHIBITING INCREASED STABILITY AND METHODS OF USE THEREOF |
| 06/17/2004 | WO2004050841A2 Casein kinase i epsilon and casein kinase i delta and sleep in humans |
| 06/17/2004 | WO2004050833A2 Glyceraldehyde 3-phosphate dehydrogenase-s(gapds), a glycolytic enzyme expressed only in male germ cells,is a target for male contraception |
| 06/17/2004 | WO2004050831A2 Compositions, organisms and methodologies employing a novel human kinase |
| 06/17/2004 | WO2004050745A1 Method for oligomerization of molecules, device therefor and use thereof |
| 06/17/2004 | WO2004050700A1 Process for preparating concentrated thrombin solutions and use in fibrin glue |
| 06/17/2004 | WO2004050117A1 Proteins involved in the regulation of energy homeostasis |
| 06/17/2004 | WO2004050116A1 Protease inhibitor |
| 06/17/2004 | WO2004050041A2 Butyrylcholinesterase variants that alter the activity of chemotherapeutic agents |
| 06/17/2004 | WO2004050007A2 Mammalian bt-42 proteins involved in the regulation of energy homeostasis |
| 06/17/2004 | WO2004038404A3 Method for optimizing therapeutic efficacy of nemorubicin |
| 06/17/2004 | WO2004035617A3 Feedback-resistant homoserine transsuccinylases |
| 06/17/2004 | WO2004033677A3 Secreted acid phosphatase (sapm) is present only in pathogenic mycobacteria and expressed selectively at acidic ph |
| 06/17/2004 | WO2004022756A3 Protein kinases |
| 06/17/2004 | WO2004018002A3 Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells |
| 06/17/2004 | WO2004016742A3 α(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND α(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM |
| 06/17/2004 | WO2004011609A3 Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
| 06/17/2004 | WO2004007686A3 Methods and transgenic mouse model for identifying and modulating factors involved in the production of reactive oxygen intermediates |
| 06/17/2004 | WO2003102213A3 Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants |
| 06/17/2004 | WO2003102138A3 Elongase genes and uses thereof |
| 06/17/2004 | WO2003087145A3 Purified polypeptides involved in quorum sensing |
| 06/17/2004 | WO2003068907A3 Method for the generation of proteins with new enzymatic function |
| 06/17/2004 | WO2003053997A3 Methods of increasing endogenous erythropoietin (epo) |
| 06/17/2004 | WO2003040392A3 Nucleic acids encoding very long chain fatty acid biosynthesis enzymes |
| 06/17/2004 | WO2003026566A3 Atlastin |
| 06/17/2004 | WO2003017992A3 Means for treatment of atherosclerosis |
| 06/17/2004 | US20040117876 Dna; promoters for gene expression of plant cells |
| 06/17/2004 | US20040117872 Expression vector comprising nucleotide sequences coding arogenate dehydrogenase for transformation and propagation of glyphosate resistant plants |
| 06/17/2004 | US20040117871 Plant growth regulation |
| 06/17/2004 | US20040117869 Comprises nucleotide sequences coding oxidoreductase for use in increasing nornicotine biosynthesis in plants |
| 06/17/2004 | US20040117865 Transposon generated genetically engineered rodent for use as tool in clarifying gene function; gene therapy and transposon mediated transformation |
| 06/17/2004 | US20040116682 Nucleic acid molecules and other molecules associated with the carbon assimilation pathway |
| 06/17/2004 | US20040116671 Novel polypeptides and nucleic acids encoding same |
| 06/17/2004 | US20040116667 Tyrosinase-related gene (TRP2) protein comprising human leukocyte antigen cytotoxic binding recognition points for identifying modulators for diagnosis, prevention and treatment of cancer ; immunotherapy |
| 06/17/2004 | US20040116659 Helicase inhibitors |
| 06/17/2004 | US20040116658 Human KAP/Cdi1-related gene variant associated with small cell lung cancer |
| 06/17/2004 | US20040116499 treatment of inflammatory or proliferative diseases of the skin and other organ systems; from yeast of the genus Malassezia; for example, 2,3-dihydro-4,5-bis(indol-3-yl)furan-2,3-dione; against multiresistent staphylococci |
| 06/17/2004 | US20040116364 antisense oligonucleotide that inhibits gene expression of death-associated protein kinase 1; diagnosis; kits; drug screening; use treating dysregulation of cellular apoptosis such as cancer |
| 06/17/2004 | US20040116355 Caspase inhibitors and the use thereof |
| 06/17/2004 | US20040116350 Contacting the cell with an antioxidant, wherein the antioxidant is effective in reducing antibody mediated generation of superoxide or hydrogen peroxide in the cell |
| 06/17/2004 | US20040115816 Modifying corynebacterial or brevibacterial genomes with plasmid vector in order to express levan sucrase; gene transfer reporter gene expression; transcriptional patterning |
| 06/17/2004 | US20040115790 Method for production of secreted proteins in fungi |
| 06/17/2004 | US20040115780 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an atteuated aspa gene |
| 06/17/2004 | US20040115776 Increasing transcription efficiency of blood coagulation factor via fusion to sequences of scaffold/matrix attachment regions (SMAR); genetic engineering and gene transfer |
| 06/17/2004 | US20040115773 Serpin in bifidobacteria |
| 06/17/2004 | US20040115772 Methods of inhibiting Helicobacter pylori |
| 06/17/2004 | US20040115763 having a beta 1,3-N-acetylglucosaminyltransferase activity; for diagnosis and treatment for inflammatory diseases, cancer or tumor metastasis |
| 06/17/2004 | US20040115762 Comprises nucleotide sequences coding enzymatic polypeptide associated biosynthesis of nystatin and treatment of bacterial, fungal and parasitic infections; immunosuppressant; antitumor agents |
| 06/17/2004 | US20040115727 Preparing tetanus and botulinum neurotoxin light chains having altered protease specificity for treatment of neurological or neurodegenerative disorders |
| 06/17/2004 | US20040115693 Novel human kinase proteins and polynucleotides encoding the same |
| 06/17/2004 | US20040115691 Mutants of enzymes and methods for their use |
| 06/17/2004 | US20040115681 Compositions and methods for modifying the content of polyunsaturated fatty acids in mammalian cells |
| 06/17/2004 | US20040115678 Dna markers for meat tenderness |
| 06/17/2004 | US20040115673 Comprises nucleotide sequences coding enzymatic polypeptide for expression and propagation in heterologous microorganisms; bioreactors and trangenic protein expression |
| 06/17/2004 | US20040115670 Identifying modulators of exopeptidase for use in diagnosis, prevention and treatment of asthma and cancer |
| 06/17/2004 | US20040115669 Comprises enzymatic polypeptide which modifies oligosaccharide for use in preparing vaccine for preventing gastroinestinal disorders |
| 06/17/2004 | US20040115662 Novel fructosyl amino acid oxidase |
| 06/17/2004 | US20040115661 Shuttle vector for use as stable gene transfer tool in genetic engineering |
| 06/17/2004 | US20040115660 Method of diagnosising abnormalities by screening for tyrosine kinase like molecules or their signalling mediators |
| 06/17/2004 | US20040115657 Methanotrophic carbon metabolism pathway genes and enzymes |
| 06/17/2004 | US20040115639 first modified thermostable enzyme exhibiting 3'exonuclease activity but no DNA polymerase activity and a second modified thermostable enzyme exhibiting DNA polymerase activity; modifier reagent is cis-aconitic anhydride or citraconic anhydride |
| 06/17/2004 | US20040115631 Nucleic acid coding for a bonding site of a protein kinase of the mitogenic signalling cascade of a clycolysis-catalysing enzyme |
| 06/17/2004 | US20040115306 Prolyl-specific endoprotease is added to the beverage |
| 06/17/2004 | US20040115202 monospecific antibody which specifically binds an epitope of a mammalian DPPIV (dipeptidyl peptidase IV, also known as CD26). |